Browsing "Hematology-Oncology" by Publication Year :

Jump to a point in the index:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 101 to 120 of 367

Pub YearTitleAuthor(s)
2019Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System정성현
2019The comparison of Carfilzomib, and dexamethasone versus pomalidomide-based combination chemotherapy after a 2nd-line therapy in relapsed and refractory multiple myeloma patients박준성
2019Abrogation of B-Raf(V600E) induced senescence by FoxM1 expression강석윤, 김장희, 박태준, 최용원
2019Loperamide overcomes the resistance of colon cancer cells to bortezomib by inducing CHOP-mediated paraptosis-like cell death최경숙, 최용원
2019A Machine-Learning Approach Using PET-Based Radiomics to Predict the Histological Subtypes of Lung Cancer고영화, 안미선, 이수진
2019Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial이현우
2019EndoTAG-1 plus gemcitabine versus gemcitabine alone in patients with measurable locally advanced and/or metastatic adenocarcinoma of the pancreas failed on FOLFIRINOX treatment강석윤
2019Does the extent of brain metastasis affect outcome of non-small cell lung cancer patients treated with chemotherapy?강석윤, 안미선, 이현우, 최용원, 최진혁
2019The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study강석윤
2019Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial강석윤
2019Capecitabine plus Oxaliplatin as a Second-Line Therapy for Advanced Biliary Tract Cancers: A Multicenter, Open-Label, Phase II Trial이현우
2019Increased CMTM6 can predict the clinical response to PD-1 inhibitors in non-small cell lung cancer patients고영화, 이현우, 정준호, 한재호, 함석진
2019The role of surgical resection before palliative chemotherapy in advanced gastric cancer강석윤, 박준성, 손상용, 신승수, 안미선, 이현우, 정성현, 최용원, 최진혁, 한상욱, 허훈
2019The impact of systemic treatment on brain metastasis in patients with non-small-cell lung cancer: A retrospective nationwide population-based cohort study강석윤, 안미선, 이현우
2019Phase II study of R-CVP followed by rituximab maintenance therapy for patients with advanced marginal zone lymphoma: consortium for improving survival of lymphoma (CISL) study정성현
2019A randomized phase II study of palbociclib plus exemestane with GNRH agonist versus capecitabine in premenopausal women with hormone receptor-positive metastatic breast cancer (KCSG-BR 15-10, NCT02592746)강석윤
2019The impact of primary tumor location in patients with metastatic colorectal cancer: a Korean Cancer Study Group CO12-04 study강석윤
2019Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma이현우
2019PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data고영화, 이수진, 이현우, 정준호, 한재호, 함석진
2019Pertuzumab, trastuzumab, and docetaxel for HER2-positive early or locally advanced breast cancer in the neoadjuvant setting: Efficacy and safety analysis of a randomized phase III study in Asian patients (PEONY)강석윤
1 2 3 4 5 6 7 8 9 10 11 19

Browse